{
  "study_metadata": {
    "study_id": "NCT01219244",
    "design": "RCT"
  },
  "exposure": {
    "label": "resveratrol",
    "comparator": "placebo"
  },
  "outcomes": [
    {
      "name": "HbA1c",
      "timepoint_weeks": 26,
      "arm_name": "intervention",
      "n": 18,
      "baseline_mean": 5.86,
      "baseline_sd": 0.36,
      "followup_mean": 5.71,
      "followup_sd": 0.33,
      "units": "%"
    },
    {
      "name": "HbA1c",
      "timepoint_weeks": 26,
      "arm_name": "control",
      "n": 22,
      "baseline_mean": 5.73,
      "baseline_sd": 0.29,
      "followup_mean": 5.71,
      "followup_sd": 0.28,
      "units": "%"
    }
  ],
  "comment_detailed": "Extracted HbA1c data from a 26‑week RCT of resveratrol vs placebo in 40 MCI patients. Baseline and follow‑up means and SDs reported for each arm. No other glycemic outcomes reported. All fields populated from text.",
  "missing_fields": [],
  "evidence": [
    "\"26 weeks of resveratrol (200 mg/d; n=18) or placebo (1,015 mg/d olive oil; n=22)\"",
    "\"HbA1c [%] 5.86±0.36 5.71 ±0.33\"",
    "\"HbA1c [%] 5.73±0.29 5.71 ±0.28\""
  ],
  "comment": "All requested fields extracted",
  "confidence": 0.9
}